Miri Wernli
Presidente en MIND MEDICINE (MINDMED) INC. .
Fortuna: 775 847 $ al 30/04/2024
Cargos activos de Miri Wernli
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MIND MEDICINE (MINDMED) INC. | Presidente | 01/02/2021 | - |
Director/Miembro de la Junta | 28/02/2020 | 11/08/2022 | |
Corporate Officer/Principal | 13/08/2020 | 01/02/2021 |
Historial de carrera de Miri Wernli
Antiguos cargos conocidos de Miri Wernli.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2007 | 01/01/2016 |
MELODIOL GLOBAL HEALTH LIMITED | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | 15/08/2020 | |
Director Técnico/Científico/I+D | 15/08/2020 | - | |
Fundador | 20/11/2015 | - |
Formación de Miri Wernli.
University of Geneva | Doctorate Degree |
Stanford University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 3 |
Australia | 2 |
Canadá | 2 |
Operativa
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
MIND MEDICINE (MINDMED) INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Bolsa de valores
- Insiders
- Miri Wernli
- Experiencia